{"transactions":[{"id":975108,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":71936,"kind":"person","name":"Masi Dina","position":1,"cik":"0001345281","reported_name":"Masi Dina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-12-10T22:09:03.000Z","date":"2025-12-09","kind":"grant","planned":false,"acquired":true,"shares":140000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in three equal annual installments with the first installment vesting on December 9, 2026."}],"balance_after":140000,"derivative":{"exercise_price":0.31,"expiration_date":"2035-12-09","underlying":"Common Stock","underlying_shares":140000},"source":{"system":"sec-edgar","filing":"0001345281-25-000011","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528125000011/primary_doc.xml","form_type":"4"}},{"id":1138016,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":71936,"kind":"person","name":"Masi Dina","position":1,"cik":"0001345281","reported_name":"Masi Dina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-05-22T21:41:44.000Z","date":"2025-05-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":135000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"72,500 of the options became exercisable on June 2, 2015 and the remaining 62,500 became exercisable in three equal annual installments beginning on June 2, 2016."}],"balance_after":0,"derivative":{"exercise_price":0.09,"expiration_date":"2025-06-02","underlying":"Common Stock","underlying_shares":135000},"source":{"system":"sec-edgar","filing":"0001345281-25-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528125000002/primary_doc.xml","form_type":"4"}},{"id":1138015,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":71936,"kind":"person","name":"Masi Dina","position":1,"cik":"0001345281","reported_name":"Masi Dina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-05-22T21:41:44.000Z","date":"2025-05-21","kind":"grant","planned":false,"acquired":true,"shares":135000,"price":0.09,"value":12150.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"135,000 common stock shares acquired upon exercise of stock option grant dated June 2, 2015."}],"balance_after":347200,"source":{"system":"sec-edgar","filing":"0001345281-25-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528125000002/primary_doc.xml","form_type":"4"}},{"id":1342020,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":71936,"kind":"person","name":"Masi Dina","position":1,"cik":"0001345281","reported_name":"Masi Dina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-12-05T17:32:16.000Z","date":"2024-12-04","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in three equal annual installments with the first installment vesting on December 4, 2025."}],"balance_after":125000,"derivative":{"exercise_price":0.31,"expiration_date":"2034-12-04","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001345281-24-000007","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528124000007/primary_doc.xml","form_type":"4"}},{"id":1353162,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":71936,"kind":"person","name":"Masi Dina","position":1,"cik":"0001345281","reported_name":"Masi Dina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-11-25T21:59:37.000Z","date":"2024-11-25","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":135000,"derivative":{"exercise_price":0.09,"exercise_date":"2015-06-02","expiration_date":"2025-06-02","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001345281-24-000005","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528124000005/primary_doc.xml","form_type":"4"}},{"id":1353161,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":71936,"kind":"person","name":"Masi Dina","position":1,"cik":"0001345281","reported_name":"Masi Dina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-11-25T21:59:37.000Z","date":"2024-11-25","kind":"grant","planned":false,"acquired":true,"shares":65000,"price":0.09,"value":5850.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"65,000 common stock shares acquired upon exercise of stock option grant dated June 2, 2015."}],"balance_after":212200,"source":{"system":"sec-edgar","filing":"0001345281-24-000005","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528124000005/primary_doc.xml","form_type":"4"}},{"id":1728015,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":71936,"kind":"person","name":"Masi Dina","position":1,"cik":"0001345281","reported_name":"Masi Dina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-11-29T22:14:37.000Z","date":"2023-11-28","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in three equal annual installments with the first installment vesting on November 28, 2024."}],"balance_after":150000,"derivative":{"exercise_price":0.24,"expiration_date":"2033-11-28","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001345281-23-000007","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528123000007/primary_doc.xml","form_type":"4"}},{"id":1775777,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":71936,"kind":"person","name":"Masi Dina","position":1,"cik":"0001345281","reported_name":"Masi Dina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-09-21T14:51:42.000Z","date":"2023-09-20","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":50000,"price":0.09,"value":4500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"50,000 stock options disposed of upon exercise of the portion of a stock option grant dated June 2, 2015.  200,000 stock options for the right to purchase common stock at $0.09 remain available to exercise."}],"balance_after":576667,"derivative":{"exercise_price":0.09,"exercise_date":"2015-06-02","expiration_date":"2025-06-02","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001345281-23-000004","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528123000004/primary_doc.xml","form_type":"4"}},{"id":1775776,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":71936,"kind":"person","name":"Masi Dina","position":1,"cik":"0001345281","reported_name":"Masi Dina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-09-21T14:51:42.000Z","date":"2023-09-20","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0.09,"value":4500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"50,000 common stock shares acquired upon exercise of stock option grant dated June 2, 2015."}],"balance_after":147200,"source":{"system":"sec-edgar","filing":"0001345281-23-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528123000004/primary_doc.xml","form_type":"4"}},{"id":2120340,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":71936,"kind":"person","name":"Masi Dina","position":1,"cik":"0001345281","reported_name":"Masi Dina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-11-10T23:27:50.000Z","date":"2022-11-09","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Exercise Price of the Stock Option will be the closing prices of the Issuer's Common Stock on the fifth trading day after the filing of the Issuer's Quarterly Report on Form 10-Q for the period ended September 30, 2022, with the Securities and Exchange Commission."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable in three equal annual installments with the first installment vesting on November 9, 2023."}],"balance_after":100000,"derivative":{"expiration_date":"2032-11-09","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001345281-22-000003","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528122000003/primary_doc.xml","form_type":"4"}},{"id":2527185,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":71936,"kind":"person","name":"Masi Dina","position":1,"cik":"0001345281","reported_name":"Masi Dina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-11-03T22:33:43.000Z","date":"2021-11-03","kind":"grant","acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Exercise Price of the Stock Option will be the closing prices of the Issuer's Common Stock five trading days after the filing of the Issuer's Quarterly Report on Form 10-Q for the period ended September 30, 2021, with the Securities and Exchange Commission."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable in three equal annual installments with the first installment vesting on November 3, 2022."}],"balance_after":65000,"derivative":{"expiration_date":"2031-11-03","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001345281-21-000001","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528121000001/primary_doc.xml","form_type":"4"}},{"id":2971691,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":71936,"kind":"person","name":"Masi Dina","position":1,"cik":"0001345281","reported_name":"Masi Dina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-11-20T21:24:54.000Z","date":"2020-11-04","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in three equal annual installments beginning on November 4, 2021."}],"balance_after":100000,"derivative":{"exercise_price":0.65,"expiration_date":"2030-11-04","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001345281-20-000001","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528120000001/primary_doc.xml","form_type":"4"}},{"id":3509218,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":71936,"kind":"person","name":"Masi Dina","position":1,"cik":"0001345281","reported_name":"Masi Dina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-05-29T19:36:32.000Z","date":"2019-05-24","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 50% (75,000) on grant date (May 24, 2019) and in three equal annual installments for the remaining 50% (75,000) beginning on May 24, 2020."}],"balance_after":150000,"derivative":{"exercise_price":0.21,"expiration_date":"2029-05-24","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001345281-19-000001","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528119000001/primary_doc.xml","form_type":"4"}}]}